SIGN UP
LOG IN
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·07/23/2025 17:06:04
Listen to the news
Gainers
- Abivax (NASDAQ:ABVX) shares increased by 552.8% to $65.28 during Wednesday's regular session. The company's market cap stands at $634.7 million.
- Anebulo Pharmaceuticals (NASDAQ:ANEB) shares moved upwards by 77.53% to $3.25. The company's market cap stands at $75.1 million.
- Clearside Biomedical (NASDAQ:CLSD) shares moved upwards by 57.54% to $0.55. The market value of their outstanding shares is at $27.3 million.
- TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 51.48% to $14.3. The company's market cap stands at $7.8 million.
- Iovance Biotherapeutics (NASDAQ:IOVA) stock rose 31.63% to $4.12. The market value of their outstanding shares is at $1.0 billion.
- aTyr Pharma (NASDAQ:ATYR) stock increased by 31.38% to $6.88. The market value of their outstanding shares is at $466.3 million.
Losers
- Hyperion DeFi (NASDAQ:HYPD) shares declined by 21.3% to $9.07 during Wednesday's regular session. The company's market cap stands at $58.8 million.
- CytoMed Therapeutics (NASDAQ:GDTC) stock declined by 12.13% to $1.77. The market value of their outstanding shares is at $23.3 million.
- GH Research (NASDAQ:GHRS) stock fell 11.21% to $14.82. The market value of their outstanding shares is at $1.0 billion.
- NeuroOne Medical Tech (NASDAQ:NMTC) shares decreased by 10.88% to $0.92. The company's market cap stands at $51.3 million.
- Nutex Health (NASDAQ:NUTX) stock declined by 10.49% to $89.53. The market value of their outstanding shares is at $556.6 million.
- Telix Pharmaceuticals (NASDAQ:TLX) stock declined by 10.48% to $14.57. The market value of their outstanding shares is at $5.4 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.